R&D Finance Team

The Research & Development Finance team are part of the main Corporate Directorate, supporting R&D across the Trust.

Research & Development Finance is split into two areas:

  • NIHR Finance
    This team looks after the large-scale funding received from NIHR (National Institute for Health Research), BRC (Biomedical Research Centre), CRN (Clinical Research Network), RCF (Research Capability Funding) and CCRC (Cambridge Clinical Research Centre).
  • Research Grants
    This team looks after the income relating to the commercial and non-commercial  (including Charities) research studies undertaken at the Trust. 

Click to see our location and view team member contact details.

Areas of Interest (in relation to R&D)
Purchase Orders Purchase Orders need to be raised for each invoice that we have to pay. This is done through the Oracle system. Certain items (Amazon, Conferences, Memberships or one-off items) still need to have POs raised via Oracle, but are purchased on-line via Procurement.
Expenses Expenses should be claimed through the EASY pay system. Please note that all expenses should follow the Trust's expenses policy.
T3 New posts, replacement posts, extension to current contracts or staff bank requests need to go through T3. The forms need to go through R&D HR first, and then Finance for approval. After this the post goes to the T3 Panel.
Patient Expenses 

These are processed by the triplicate forms available from R&D Finance. At the visit the nurse or Investigator should complete the form with the patient details and the costs to be reclaimed.

  1. The top copy (white) can either be sent to Accounts Payable (Box 130) and a cheque will be issued to the patient at their home address, or the patient can take the form to the Cashiers desk in the Concourse to be paid directly.
  2. The middle copy (yellow) needs to be sent to R&D Finance - we use this to reconcile the patient expenses costs and to claim the costs back from the sponsor.
  3. The bottom copy (pink) should stay in the department in the patient's file.
VAT Please see separate page VAT Guidance for Researchers.
Excess Treatment Costs Excess Treatment Costs (ETCs) arise when the cost of treatment being researched is different to the cost of the standard patient care pathway. This process is currently under review by the CRN and will be updated shortly.
Subvention Funding In exceptional circumstances, where ETCs are very high, the Dept of Health Research and Development Directorate (DH RDD) may provide a contribution towards funding them via subvention funding. Applications for subvention funding can only be made by a Chief Investigator  of a research study once they have received notification funding (at least in principle) from the researcher funder. (Further guidance on applying for subvention funding can be found in the AcoRD guidance.)